These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14552697)

  • 1. COX-2 and COX-2 enzyme inhibition.
    Conti P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 3. [Topical pharmacology. COX-2 inhibitors].
    Heinzl S
    Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D
    MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
    [No Abstract]   [Full Text] [Related]  

  • 5. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S; Crofford LJ
    Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute interstitial nephritis and COX-2 inhibition.
    Chow KM; Szeto CC; Li P; Lai FM
    Hosp Med; 2003 Jul; 64(7):429. PubMed ID: 12886856
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
    Shi G
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 10. New treatment options for Bartter's syndrome.
    Kleta R; Basoglu C; Kuwertz-Bröking E
    N Engl J Med; 2000 Aug; 343(9):661-2. PubMed ID: 10979805
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective COX-2 inhibitor. Stomach protection--but not always].
    MMW Fortschr Med; 2001 Jun; 143(25):60. PubMed ID: 11469005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
    MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
    [No Abstract]   [Full Text] [Related]  

  • 14. HMO drug formulary access increases for COX-2s.
    Manag Care; 2002 Oct; 11(10):48. PubMed ID: 12415909
    [No Abstract]   [Full Text] [Related]  

  • 15. New versus old drugs for arthritis.
    Health News; 1999 Nov; 5(14):7. PubMed ID: 10624169
    [No Abstract]   [Full Text] [Related]  

  • 16. COX-2 inhibition and the control of pain.
    Kiefer W; Dannhardt G
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COX-2 inhibitors: current status and outlook].
    Dannhardt G; Hahn L
    Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib.
    Bannwarth B; Ravaud P; Dougados M
    J Rheumatol; 2003 Feb; 30(2):421-2. PubMed ID: 12583353
    [No Abstract]   [Full Text] [Related]  

  • 19. When to try COX-2-specific inhibitors. Safer than standard NSAIDs in some situations.
    Rehman Q; Sack KE
    Postgrad Med; 1999 Oct; 106(4):95-7, 101-2, 105-6. PubMed ID: 10533511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second selective COX-2 inhibitor receives marketing approval.
    Miller JL
    Am J Health Syst Pharm; 1999 Jul; 56(13):1294. PubMed ID: 10683121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.